UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (672) 672
phosphoinositide-3 kinase inhibitors (642) 642
life sciences & biomedicine (627) 627
humans (541) 541
animals (468) 468
phosphatidylinositol 3-kinases - metabolism (437) 437
enzyme inhibitors - pharmacology (321) 321
biochemistry & molecular biology (299) 299
morpholines - pharmacology (272) 272
mice (260) 260
chromones - pharmacology (250) 250
signal transduction (226) 226
signal transduction - drug effects (203) 203
cell line, tumor (174) 174
proto-oncogene proteins c-akt - metabolism (170) 170
phosphorylation (161) 161
male (142) 142
apoptosis - drug effects (135) 135
female (135) 135
androstadienes - pharmacology (133) 133
wortmannin (132) 132
rats (131) 131
apoptosis (124) 124
cells, cultured (123) 123
cell line (122) 122
protein kinase inhibitors - pharmacology (120) 120
oncology (118) 118
1-phosphatidylinositol 3-kinase (102) 102
antineoplastic agents - pharmacology (97) 97
phosphoinositide-3 kinase inhibitors - pharmacology (97) 97
abridged index medicus (93) 93
proto-oncogene proteins c-akt - antagonists & inhibitors (92) 92
cell biology (91) 91
proto-oncogene proteins c-akt (91) 91
hematology (90) 90
cell proliferation - drug effects (89) 89
phosphatidylinositol 3-kinases - genetics (87) 87
cancer (86) 86
biological and medical sciences (85) 85
proto-oncogene proteins - metabolism (80) 80
akt protein (79) 79
kinases (79) 79
enzyme activation (75) 75
mutation (75) 75
phosphorylation - drug effects (71) 71
transfection (70) 70
tor serine-threonine kinases - antagonists & inhibitors (69) 69
dose-response relationship, drug (68) 68
cell survival - drug effects (66) 66
blotting, western (61) 61
medical sciences (61) 61
proteins (61) 61
pharmacology & pharmacy (59) 59
cell proliferation (57) 57
tumor cells, cultured (57) 57
pi3k (54) 54
enzyme activation - drug effects (53) 53
tor serine-threonine kinases - metabolism (53) 53
phosphatidylinositol 3-kinases - physiology (52) 52
signal transduction - physiology (51) 51
tumors (51) 51
mitogen-activated protein kinases - metabolism (50) 50
protein-serine-threonine kinases (50) 50
analysis (48) 48
pyrimidines - pharmacology (47) 47
protein-serine-threonine kinases - metabolism (46) 46
rats, sprague-dawley (46) 46
time factors (46) 46
science & technology - other topics (45) 45
xenograft model antitumor assays (45) 45
flavonoids - pharmacology (44) 44
inhibitors (44) 44
multidisciplinary sciences (43) 43
gene expression (42) 42
research article (42) 42
mice, inbred balb c (41) 41
mice, nude (39) 39
research (39) 39
middle aged (37) 37
akt (36) 36
antineoplastic agents - therapeutic use (36) 36
map kinase signaling system - drug effects (36) 36
cell cycle (35) 35
cell movement - drug effects (35) 35
imidazoles - pharmacology (35) 35
signaling (35) 35
cell survival (34) 34
drug synergism (34) 34
mice, inbred c57bl (34) 34
adult (33) 33
breast cancer (33) 33
medicine (33) 33
protein binding (33) 33
proto-oncogene proteins c-akt - genetics (33) 33
quinolines - pharmacology (33) 33
rna, messenger - metabolism (33) 33
phosphoinositide-3 kinase (32) 32
protein-tyrosine kinases - metabolism (32) 32
science (32) 32
tor protein (32) 32
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Bouhaddou, Mehdi and Memon, Danish and Meyer, Bjoern and White, Kris M and Rezelj, Veronica V and Correa Marrero, Miguel and Polacco, Benjamin J and Melnyk, James E and Ulferts, Svenja and Kaake, Robyn M and Batra, Jyoti and Richards, Alicia L and Stevenson, Erica and Gordon, David E and Rojc, Ajda and Obernier, Kirsten and Fabius, Jacqueline M and Soucheray, Margaret and Miorin, Lisa and Moreno, Elena and Koh, Cassandra and Tran, Quang Dinh and Hardy, Alexandra and Robinot, Rémy and Vallet, Thomas and Nilsson-Payant, Benjamin E and Hernandez-Armenta, Claudia and Dunham, Alistair and Weigang, Sebastian and Knerr, Julian and Modak, Maya and Quintero, Diego and Zhou, Yuan and Dugourd, Aurelien and Valdeolivas, Alberto and Patil, Trupti and Li, Qiongyu and Hüttenhain, Ruth and Cakir, Merve and Muralidharan, Monita and Kim, Minkyu and Jang, Gwendolyn and Tutuncuoglu, Beril and Hiatt, Joseph and Guo, Jeffrey Z and Xu, Jiewei and Bouhaddou, Sophia and Mathy, Christopher J.P and Gaulton, Anna and Manners, Emma J and Félix, Eloy and Shi, Ying and Goff, Marisa and Lim, Jean K and McBride, Timothy and O’Neal, Michael C and Cai, Yiming and Chang, Jason C.J and Broadhurst, David J and Klippsten, Saker and De wit, Emmie and Leach, Andrew R and Kortemme, Tanja and Shoichet, Brian and Ott, Melanie and Saez-Rodriguez, Julio and tenOever, Benjamin R and Mullins, R. Dyche and Fischer, Elizabeth R and Kochs, Georg and Grosse, Robert and García-Sastre, Adolfo and Vignuzzi, Marco and Johnson, Jeffery R and Shokat, Kevan M and Swaney, Danielle L and Beltrao, Pedro and Krogan, Nevan J
Cell (Cambridge), ISSN 0092-8674, 08/2020, Volume 182, Issue 3, pp. 685 - 712.e19
phosphoproteomics | SARS-CoV-2 | PIKFYVE | p38 | AXL | antiviral | casein kinase II | mass spectrometry | CDK | MAPK | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Phosphorylation | Cyclin-Dependent Kinases - metabolism | Pandemics | Humans | Phosphatidylinositol 3-Kinases - metabolism | COVID-19 | Pneumonia, Viral - metabolism | Peptidyl-Dipeptidase A - genetics | Coronavirus Infections - metabolism | HEK293 Cells | Peptidyl-Dipeptidase A - metabolism | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | p38 Mitogen-Activated Protein Kinases - metabolism | Cyclin-Dependent Kinases - antagonists & inhibitors | Proteomics - methods | Vero Cells | Caco-2 Cells | Phosphoinositide-3 Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins - metabolism | A549 Cells | Drug Evaluation, Preclinical - methods | Proto-Oncogene Proteins - antagonists & inhibitors | Antiviral Agents - pharmacology | Chlorocebus aethiops | Spike Glycoprotein, Coronavirus - metabolism | Casein Kinase II - antagonists & inhibitors | Betacoronavirus - metabolism | Receptor Protein-Tyrosine Kinases - metabolism | Host-Pathogen Interactions | Angiotensin-Converting Enzyme 2 | Animals | Coronavirus Infections - virology | p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors | Protein Kinase Inhibitors - pharmacology | Pneumonia, Viral - virology | Casein Kinase II - metabolism | Antiviral agents | Viral proteins | Casein | Severe acute respiratory syndrome | Analysis | Coronaviruses | Health aspects | Mass spectrometry | Index Medicus
Journal Article
Journal Article
Clinical cancer research, ISSN 1078-0432, 01/2013, Volume 19, Issue 1, pp. 279 - 290
Journal Article
Blood, ISSN 0006-4971, 07/2017, Volume 130, Issue 3, pp. 310 - 322
Life Sciences & Biomedicine | Hematology | Science & Technology | Phosphoinositide-3 Kinase Inhibitors | Apoptosis - drug effects | Protein-Tyrosine Kinases - metabolism | Humans | Gene Expression Regulation, Neoplastic | NF-kappa B - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Proto-Oncogene Proteins c-akt - genetics | Protein-Tyrosine Kinases - genetics | Piperidines - pharmacology | Oxadiazoles - pharmacology | Antineoplastic Agents - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Pyrazoles - pharmacology | PTEN Phosphohydrolase - genetics | NF-kappa B - antagonists & inhibitors | PTEN Phosphohydrolase - deficiency | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Signal Transduction | Pyrimidines - pharmacology | Organ Specificity | Proto-Oncogene Proteins c-myc - metabolism | Drug Synergism | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Pyrroles - pharmacology | Animals | NF-kappa B - genetics | Agammaglobulinaemia Tyrosine Kinase | Lymphoma, Large B-Cell, Diffuse - classification | Proto-Oncogene Proteins c-myc - antagonists & inhibitors | Mice | Protein Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins c-myc - genetics | Lymphoma, Large B-Cell, Diffuse - genetics | Drug Combinations | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Drug Screening Assays, Antitumor | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Cancer science, ISSN 1347-9032, 10/2018, Volume 109, Issue 10, pp. 3183 - 3196
MEK inhibitor | compensatory activation | acquired resistance | non‐small cell lung cancer | PI3K inhibitor | non-small cell lung cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Phosphoinositide-3 Kinase Inhibitors | Humans | ErbB Receptors - genetics | Epithelial-Mesenchymal Transition - drug effects | Lung Neoplasms - pathology | Phosphatidylinositol 3-Kinases - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Mitogen-Activated Protein Kinase Kinases - metabolism | Female | Pyrimidinones - pharmacology | Imidazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Oxazepines - therapeutic use | ErbB Receptors - antagonists & inhibitors | Pyrimidinones - therapeutic use | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Imidazoles - pharmacology | Oxazepines - pharmacology | Drug Synergism | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Protein Kinase Inhibitors - therapeutic use | Cell Line, Tumor | Cell Proliferation - drug effects | Mice, Inbred BALB C | Protein Kinase Inhibitors - pharmacology | Pyridones - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Pyridones - pharmacology | Drug Resistance, Neoplasm - drug effects | Lung cancer, Small cell | Cellular signal transduction | Epidermal growth factor | Analysis | Tyrosine | Phosphorylation | Epidermal growth factor receptors | Mesenchyme | Lung cancer | Extracellular signal-regulated kinase | Clinical trials | Non-small cell lung carcinoma | MAP kinase | AKT protein | Drug resistance | 1-Phosphatidylinositol 3-kinase | c-Met protein | Signal transduction | Cell activation | Cell growth | Feedback | Stem cells | Protein-tyrosine kinase | Apoptosis | Tumors | Index Medicus | Original
Journal Article